---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-020081"
form_type: "8-K"
ticker: "ALLR"
cik: "0001860657"
company_name: "Allarity Therapeutics, Inc."
filed_at: "2025-06-11T23:59:59+00:00"
generated_at: "2026-05-19T14:02:46.653568+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Allarity Therapeutics appoints Jesper Høiland to board, replacing Joseph Vazzano

## Summary
- Joseph Vazzano resigned as director effective June 30, 2025.
- Jesper Høiland appointed director effective June 30, 2025; term expires at 2026 annual meeting.
- Høiland joins Audit, Compensation, and Nominating & Governance Committees.
- Høiland receives $50,000 annual retainer plus committee fees ($7,500/$5,000/$4,000).
- Høiland had served as strategic consultant since Oct 2024; background includes Novo Nordisk and Radius Health.

## SEC filing metadata
- accession: 0001437749-25-020081
- form_type: 8-K
- ticker: ALLR
- cik: 0001860657
- company_name: Allarity Therapeutics, Inc.
- filed_at: 2025-06-11T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1860657/000143774925020081/0001437749-25-020081-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1860657/000143774925020081/allr20250611_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-020081
- JSON: https://secwatch.observer/filing/0001437749-25-020081.json
- Plain text: https://secwatch.observer/filing/0001437749-25-020081.txt

## Key facts
- Executive change
  Jesper Høiland was appointed as director at Allarity Therapeutics, Inc..
  - Action: appointed
  - Role: director
  source text: On June 10, 2025, the Board appointed Mr. Jesper Høiland as a director of the Company, effective as of June 30, 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1860657/000143774925020081/0001437749-25-020081-index.htm
- Executive change
  Joseph W. Vazzano resigned as director at Allarity Therapeutics, Inc..
  - Action: resigned
  - Role: director
  source text: On June 5, 2025, the Board of Directors (the “ Board ”) of Allarity Therapeutics, Inc. (the “ Company ”) received the resignation of Joseph W. Vazzano as director of the Company, effective June 30, 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1860657/000143774925020081/0001437749-25-020081-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.